Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

32.43

-0.27 (-0.83%)

At close: Jul 6, 2026, 4:00 PM EDT

33.00

+0.57 (1.76%)

After-hours: Jul 6, 2026, 7:19 PM EDT

Stoke Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	155.66	84.71	128.06	191.44	113.56	144.9
Short-Term Investments	187.89	200.45	88.92	9.95	116.04	74.92
Cash & Short-Term Investments	343.55	285.16	216.97	201.39	229.6	219.81
Cash Growth	-3.88%	31.43%	7.74%	-12.28%	4.45%	-23.49%
Accounts Receivable	4.45	5.94	1.67	-	-	-
Other Receivables	1.69	1.97	0.7	0.06	0.59	0.13
Total Trade Receivables	6.14	7.91	2.37	0.06	0.59	0.13
Other Current Assets	17	12.63	13.41	13.88	13.89	9.28
Total Current Assets	366.68	305.7	232.76	215.34	244.07	229.22
Net Property, Plant & Equipment	5.89	6.25	8.25	12.43	11.43	9.08
Long-Term Investments	67.48	106.26	29.82	-	-	-
Other Long-Term Assets	3.23	0.23	0.72	0.57	0.57	0.57
Total Assets	443.28	418.43	271.56	228.34	256.07	238.87
Accounts Payable	6.84	4.94	2.5	1.7	0.77	2.39
Accrued Expenses	23.9	41.04	18.57	13.82	15.75	14.75
Unearned Revenue	10.07	11.9	18.99	15.31	14.88	-
Total Current Liabilities	40.81	57.88	40.06	30.82	31.39	17.14
Other Long-Term Liabilities	7.59	8.1	2.48	37.96	39.82	3.95
Total Long-Term Liabilities	7.59	8.1	2.48	37.96	39.82	3.95
Total Liabilities	48.4	65.98	42.53	68.78	71.22	21.09
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	942.7	849.62	720	561.43	483.17	414.02
Accumulated Other Comprehensive Income	-0.12	0.54	-0.15	-0.02	-1.18	-0.17
Retained Earnings	-547.72	-497.72	-490.83	-401.85	-297.15	-196.08
Shareholders' Equity	394.88	352.46	229.02	159.57	184.85	217.78
Total Liabilities & Equity	443.28	418.43	271.56	228.34	256.07	238.87
Net Cash (Debt)	343.55	285.16	216.97	201.39	229.6	219.81
Net Cash Growth	20.47%	31.43%	7.74%	-12.28%	4.45%	-23.49%
Net Cash Per Share	5.83	4.82	4.02	4.58	5.90	5.98
Book Value	394.88	352.46	229.02	159.57	184.85	217.78
Book Value Per Share	6.70	5.95	4.24	3.63	4.75	5.93
Tangible Book Value	394.88	352.46	229.02	159.57	184.85	217.78
Tangible Book Value Per Share	6.70	5.95	4.24	3.63	4.75	5.93

SEC Filings: 10-K · 10-Q